Comparison of endoscopic gastritis based on Kyoto classification between diffuse and intestinal gastric cancer
暂无分享,去创建一个
S. Yoshida | O. Toyoshima | K. Koike | Hayato Nakagawa | Tomonori Aoki | T. Nishizawa | Hidekazu Suzuki | Y. Tsuji | Kosuke Sakitani | Fumiko Nagura
[1] C. Tanikawa,et al. Endoscopy-based Kyoto classification score of gastritis related to pathological topography of neutrophil activity , 2020, World journal of gastroenterology.
[2] C. Tanikawa,et al. The simplified Kyoto classification score is consistent with the ABC method of classification as a grading system for endoscopic gastritis , 2020, Journal of clinical biochemistry and nutrition.
[3] P. Moayyedi,et al. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis , 2020, Gut.
[4] Shen Xin,et al. Risk factors of tumor invasion and node metastasis in early gastric cancer with undifferentiated component: a multicenter retrospective study on biopsy specimens and clinical data , 2020, Annals of translational medicine.
[5] M. Nojima,et al. Validity of endoscopic features for the diagnosis of Helicobacter pylori infection status based on the Kyoto classification of gastritis , 2020, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.
[6] D. Murawa,et al. Yield of staging laparoscopy in gastric cancer is influenced by Laurén histologic subtype , 2019, Journal of surgical oncology.
[7] Jong-Lyul Park,et al. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer , 2019, Gastric Cancer.
[8] K. Yokota,et al. Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication , 2019, Journal of Gastroenterology.
[9] F. Mégraud,et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideli , 2019, Endoscopy.
[10] T. Omori,et al. Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma , 2019, World Journal of Surgical Oncology.
[11] J. Ji,et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] R. Fossmark,et al. Types of Gastric Carcinomas , 2018, International journal of molecular sciences.
[13] N. Yamamichi,et al. Serum anti-Helicobacter pylori antibody titer and its association with gastric nodularity, atrophy, and age: A cross-sectional study , 2018, World journal of gastroenterology.
[14] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[15] K. Yao,et al. Clinical predictors of histologic type of gastric cancer. , 2017, Gastrointestinal endoscopy.
[16] K. Koike,et al. Association between gastric cancer and the Kyoto classification of gastritis , 2017, Journal of gastroenterology and hepatology.
[17] Alberto Carmona-Bayonas,et al. Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry , 2017, British Journal of Cancer.
[18] O. Inatomi,et al. Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer , 2017, Internal medicine.
[19] S. Barni,et al. Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis. , 2017, Journal of gastrointestinal oncology.
[20] S. Zeng,et al. Lauren classification and individualized chemotherapy in gastric cancer , 2016, Oncology letters.
[21] K. Yao,et al. Histologic differentiation and mucin phenotype in white opaque substance-positive gastric neoplasias , 2015, Endoscopy International Open.
[22] K. Yao,et al. Absent microsurface pattern is characteristic of early gastric cancer of undifferentiated type: magnifying endoscopy with narrow-band imaging. , 2014, Gastrointestinal endoscopy.
[23] E. Bollschweiler,et al. Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. , 2014, World journal of gastroenterology.
[24] Sang Kil Lee,et al. Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: do we have enough data to support this? , 2014, World journal of gastroenterology.
[25] Hyojin Park,et al. Undifferentiated early gastric cancer diagnosed as differentiated histology based on forceps biopsy. , 2013, Pathology, research and practice.
[26] S. Choi,et al. Clinical implication of endoscopic gross appearance in early gastric cancer: revisited , 2013, Surgical Endoscopy.
[27] T. Shimbo,et al. Endoscopic diagnosis of gastric mucosal activity and inflammation , 2013, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.
[28] N. Yamamichi,et al. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis , 2012, International journal of cancer.
[29] H. Jung,et al. Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high‐incidence region of Korea , 2012, International journal of cancer.
[30] Yusuke Nakamura,et al. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer , 2008, Nature Genetics.
[31] K. Chayama,et al. NODULAR GASTRITIS WITH HELICOBACTER PYLORI INFECTION IS STRONGLY ASSOCIATED WITH DIFFUSE‐TYPE GASTRIC CANCER IN YOUNG PATIENTS , 2007 .
[32] T. Wang,et al. Inflammation, atrophy, and gastric cancer. , 2007, The Journal of clinical investigation.
[33] P. Malfertheiner,et al. Helicobacter pylori and molecular events in precancerous gastric lesions , 2004, Alimentary pharmacology & therapeutics.
[34] Y. Matsuzawa,et al. Helicobacter pylori‐induced enlarged‐fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma , 2003, Journal of gastroenterology and hepatology.
[35] Toshiyuki Matsui,et al. Novel magnified endoscopic findings of microvascular architecture in intramucosal gastric cancer. , 2002, Gastrointestinal endoscopy.
[36] T. Yoshimura,et al. Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989 , 2001, British Journal of Cancer.
[37] L. Hansson,et al. Can endoscopic biopsy specimens be used for reliable Laurén classification of gastric cancer? , 1996, Scandinavian journal of gastroenterology.
[38] G. Olafsdóttir,et al. Gastric carcinoma: Correlation of diagnosis based on biopsies and resection specimens with reference to the Laurén classification , 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[39] T. Takemoto,et al. An Endoscopic Recognition of the Atrophic Border and its Significance in Chronic Gastritis , 1969 .
[40] P. Laurén,et al. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.
[41] R. P. Blankfield,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.